News Release
INDIANAPOLIS – Eli Lilly and Co. is facing a product liability lawsuit filed in Indiana by a North Carolina man who alleges the pharmaceutical company failed to adequately warn patients about the risk of severe digestive complications associated with its GLP-1 medications.
The 61-year-old plaintiff claims he developed gastroparesis after taking two Lilly medications prescribed by his physician in 2023. The condition impairs stomach contractions and slows the movement of food through the digestive system, potentially causing persistent nausea, vomiting and abdominal pain…